![Luis Peña](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luis Peña
Founder at
EVOMMUNE, INC.
Net worth: 15 M $ as of 31/05/2026
Profile
Luis C.
Peña was the founder of Dermira, Inc., founded in 2010, where the title held was Chief Development Officer.
Former jobs include Senior Director-Project Planning & Management at Innoviva, Inc., Principal at Genentech, Inc., Vice President-Portfolio Planning & Management at Connetics Corp.
from 2005 to 2007, Vice President-Product Development at Nuvelo, Inc. from 2001 to 2005, and VP & Head-Global Prescription Development at Stiefel Laboratories, Inc. from 2010 to 2011.
Education includes undergraduate studies at San Francisco State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EVOMMUNE, INC. 1.75% | 22/06/2026 | 630,458 ( 1.75% ) | 15 M $ | 31/05/2026 |
Luis Peña active positions
| Companies | Position | Start |
|---|---|---|
| EVOMMUNE, INC. | Founder | 01/04/2020 |
Former positions of Luis Peña
| Companies | Position | End |
|---|---|---|
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/03/2011 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Corporate Officer/Principal | 01/01/2007 |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Corporate Officer/Principal | 01/01/2005 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Training of Luis Peña
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
San Francisco State University
 San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Luis Peña
